Indexed under tirzepatide as a PubMed major topic

Every paper here, unless its row says otherwiseIndexed under tirzepatide in PubMed

• Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review.

  Clinical obesity2026PMID 40832978

• Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial.

  Diabetes, obesity & metabolism2026PMID 41187971

• Tirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial.

  Annals of the rheumatic diseases2026PMID 41198460

• The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis.

  Expert opinion on drug safety2026PMID 41200927

• Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.

  Diabetes, obesity & metabolism2026PMID 41290555

• Safety and effectiveness of tirzepatide during Ramadan fasting: Real-world evidence from patients with type 2 diabetes in Bangladesh.

  Diabetes, obesity & metabolism2026PMID 41342185

• Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.

  Diabetologia2026PMID 41419618

• A Systematic Review Identifying Critical Evidence Gaps in Reporting Dietary Change in Randomized Controlled Trials Prescribing Liraglutide, Semaglutide, or Tirzepatide.

  Obesity reviews2026PMID 41491340

• Effectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: A real-world observational study.

  Diabetes, obesity & metabolism2026PMID 41532325

• Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study.

  Hepatology international2026PMID 41535629

• Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies.

  Postgraduate medical journal2026PMID 41536268

• Digital Engagement Significantly Enhances Weight Loss Outcomes in Adults With Obesity Treated With Tirzepatide: Retrospective Cohort Study of a Digital Weight Loss Service.

  Journal of medical Internet research2026PMID 41538282

• Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial.

  Nature medicine2026PMID 41540105

• Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter US Cohort Study.

  Ophthalmology2026PMID 41577258

• Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT-1 Trial.

  Obesity (Silver Spring, Md.)2026PMID 41612966

• Ocular Outcomes with Tirzepatide versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes.

  Ophthalmology. Retina2026PMID 41655764

• Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study.

  Journal of endocrinological investigation2026PMID 41661445

• Real-world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi-site retrospective study.

  Diabetes, obesity & metabolism2026PMID 41674229

• Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.

  Diabetes, obesity & metabolism2026PMID 41705736

• Semaglutide vs tirzepatide in patients with obesity and HFpEF: a report from a global federated research network.

  ESC heart failure2026PMID 41711744

• Head-to-head comparison of tirzepatide and semaglutide for weight loss: A systematic review and meta-analysis.

  Obesity research & clinical practice2026PMID 41723034

• Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.

  Cardiovascular diabetology2026PMID 41761267

• Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes.

  Diabetes technology & therapeutics2026PMID 41804540

• Comparative Analysis of Efficacy and Safety of the Glucagon-Like-Peptide-1 Receptor Agonists Tirzepatide and Semaglutide in Solid-Organ Transplant Recipients.

  Experimental and clinical transplantation2026PMID 41808646

• Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.

  The American journal of cardiology2026PMID 41862113

• Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis.

  Disease-a-month2026PMID 41862384

• Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy.

  The Journal of clinical endocrinology and metabolism2026PMID 41866320

• Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.

  JAMA network open2026PMID 41885866

• Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults.

  Diabetes, obesity & metabolism2026PMID 41891334

• The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.

  BMC medicine2026PMID 41896878

• Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide.

  Obesity (Silver Spring, Md.)2026PMID 41902614

• Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.

  Arthritis & rheumatology (Hoboken, N.J.)2026PMID 41903163

• Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial.

  JAMA cardiology2026PMID 41903177

• Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH.

  BMJ open diabetes research & care2026PMID 41912265

• Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

  Diabetes, obesity & metabolism2026PMID 41944182

• Short-Term Associations Between Fat-Free Mass Preservation and Glycaemic Markers During Tirzepatide Therapy: A Secondary Exploratory Analysis.

  Nutrients2026PMID 41978142

• Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial.

  Cardiovascular revascularization medicine2026PMID 42000295

• Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence.

  Endocrinology, diabetes & metabolism2026PMID 42007544

• Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.

  Diabetes research and clinical practice2026PMID 42009260

• Six-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.

  Diabetes, obesity & metabolism2026PMID 42037110

• Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.

  Diabetes, obesity & metabolism2026PMID 42050884

• Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

  Nutrients2026PMID 42075085

• Short-term effect of tirzepatide on serum calcitonin in adults with obesity.

  Endocrine2026PMID 42081121

• Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

  Journal of endocrinological investigation2026PMID 42082865

• Pre-Pregnancy GLP-1 Receptor Agonist or Tirzepatide Use and Gestational Diabetes Risk: Evaluating Pharmacodynamic Carry-Over Versus Post-Discontinuation Metabolic Rebound in a Multinational Federated Cohort.

  Diabetes, obesity & metabolism2026PMID 42098901

• Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.

  Diabetes, obesity & metabolism2026PMID 42108080

• Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.

  Lancet (London, England)2026PMID 42119587

• Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.

  JAMA dermatology2026PMID 42139049

• Impact of Tirzepatide Therapy on Thyroid Disease: Understanding Risks and Emerging Insights.

  Clinical obesity2026PMID 42145153

• Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial.

  Annals of internal medicine2026PMID 42184419